She clearly has not answered the question in the webinar as you say
However in the auszbiz interview she clearly states the following
And I quote
(3:09 minutes into feed)
"And through that engagement what we would get is that equity in whatever the asset is. And the most successful scenario would be that Petalion does develop quite a novel therapy using our dendrimer technology, and there is a successful exit and that's when we have our 22.5% equity gain"
Big Pharma or Venture Capitalists, page-18
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
